# Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer

> **NCT02792842** · PHASE2 · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 79 (actual)

## Conditions studied

- Postoperative Stage II/III Colon Cancer

## Interventions

- **DRUG:** ART-123 (3-day ART)
- **DRUG:** ART-123 (1-day ART)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02792842
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792842, "Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02792842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*